Technical Analysis for PFE - Pfizer Inc CDR
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 13.920 | 1.98% | 0.270 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 50 DMA | Bullish | 1.98% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 1.98% | |
NR7 | Range Contraction | 1.98% | |
Narrow Range Bar | Range Contraction | 1.98% | |
Inside Day | Range Contraction | 1.98% | |
BB Squeeze Ended | Range Expansion | 1.98% | |
Overbought Stochastic | Strength | 1.98% | |
Fell Below 50 DMA | Bearish | 2.50% | |
20 DMA Support | Bullish | 2.50% | |
Bollinger Band Squeeze | Range Contraction | 2.50% |
Alert | Time |
---|---|
Up 1 ATR | about 3 hours ago |
Upper Bollinger Band Resistance | about 4 hours ago |
Non-ADX 1,2,3,4 Pullback Entry | about 4 hours ago |
Rose Above Previous Day's High | about 4 hours ago |
Rose Above Upper Bollinger Band | about 4 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 2024-10-29
Pfizer Inc CDR Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Biotechnology Biopharmaceutical Contract Manufacturing Immunosuppressants Immunotherapies Infectious Diseases Migraine
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 16.11 |
52 Week Low | 11.83 |
Average Volume | 51,278 |
200-Day Moving Average | 13.192 |
50-Day Moving Average | 13.620 |
20-Day Moving Average | 13.479 |
10-Day Moving Average | 13.522 |
Average True Range | 0.261 |
RSI (14) | 56.14 |
ADX | 15.42 |
+DI | 19.481 |
-DI | 21.842 |
Chandelier Exit (Long, 3 ATRs) | 13.089 |
Chandelier Exit (Short, 3 ATRs) | 13.782 |
Upper Bollinger Bands | 13.845 |
Lower Bollinger Band | 13.114 |
Percent B (%b) | 0.73 |
BandWidth | 5.423 |
MACD Line | 0.020 |
MACD Signal Line | -0.021 |
MACD Histogram | 0.0411 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 13.845 | ||||
Resistance 3 (R3) | 13.823 | 13.737 | 13.813 | ||
Resistance 2 (R2) | 13.737 | 13.687 | 13.748 | 13.802 | |
Resistance 1 (R1) | 13.693 | 13.656 | 13.715 | 13.715 | 13.791 |
Pivot Point | 13.607 | 13.607 | 13.618 | 13.618 | 13.607 |
Support 1 (S1) | 13.563 | 13.557 | 13.585 | 13.585 | 13.509 |
Support 2 (S2) | 13.477 | 13.526 | 13.488 | 13.498 | |
Support 3 (S3) | 13.433 | 13.477 | 13.488 | ||
Support 4 (S4) | 13.455 |